[HTML][HTML] Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
SP Gadani, M Reyes-Mantilla, L Jank, S Harris… - …, 2021 - thelancet.com
Background Sphingosine-1-phosphate receptor (S1P) modulators and anti-CD20 therapies
impair humoral responses to SARS-CoV-2 mRNA vaccines. Relatively few studies have …
impair humoral responses to SARS-CoV-2 mRNA vaccines. Relatively few studies have …
[HTML][HTML] Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
…, T Bedke, E Javidi, B Rissiek, L Jank… - Journal of …, 2021 - Springer
Background Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T
cells are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With …
cells are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With …
[HTML][HTML] Current approaches and future perspectives for nanobodies in stroke diagnostic and therapy
L Jank, C Pinto-Espinoza, Y Duan, F Koch-Nolte… - Antibodies, 2019 - mdpi.com
Antibody-based biologics are the corner stone of modern immunomodulatory therapy. Though
highly effective in dampening systemic inflammatory processes, their large size and Fc-…
highly effective in dampening systemic inflammatory processes, their large size and Fc-…
Decompressive craniectomy in malignant MCA infarction in times of mechanical thrombectomy
J Göttsche, F Flottmann, L Jank, G Thomalla… - Acta …, 2020 - Springer
Background Mechanical thrombectomies (MT) in stroke have changed the standard treatment
regimen with a continuous increase of MTs during the last years. A subsequent reduction …
regimen with a continuous increase of MTs during the last years. A subsequent reduction …
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
L Jank, P Bhargava - Neurologic clinics, 2024 - neurologic.theclinics.com
The gut microbiome is a mixture of bacteria, fungi, and viruses that inhabit the intestinal lumen.
In healthy individuals the colonizing microbes and host mutually benefit each other. The …
In healthy individuals the colonizing microbes and host mutually benefit each other. The …
[HTML][HTML] Ecto-ADP-ribosyltransferase ARTC2. 1 functionally modulates FcγR1 and FcγR2B on murine microglia
…, S Menzel, M Leutert, M Cordes, S Behr, L Jank… - Scientific reports, 2017 - nature.com
Mammalian ecto-ADP-ribosyltransferases (ecto-ARTs or also ARTCs) catalyze the ADP-ribosylation
of cell surface proteins using extracellular nicotinamide adenine dinucleotide (NAD …
of cell surface proteins using extracellular nicotinamide adenine dinucleotide (NAD …
[HTML][HTML] BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain …
Multiple sclerosis (MS) has traditionally been viewed as a chronic inflammatory disease
affecting the white matter of the central nervous system. However, over the past two decades, …
affecting the white matter of the central nervous system. However, over the past two decades, …
The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future …
Recent evidence suggests that the glucagon-like peptide-1 receptor (GLP-1R) agonists have
neuroprotective activities in the CNS in animal models of Parkinson’s disease, Alzheimer’s …
neuroprotective activities in the CNS in animal models of Parkinson’s disease, Alzheimer’s …
Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease
…, KL Harrison, MD Smith, K Solem, S Gadani, L Jank… - medRxiv, 2024 - medrxiv.org
Background Bile acid metabolism is altered in multiple sclerosis (MS) and tauroursodeoxycholic
acid (TUDCA) supplementation ameliorated disease in mouse models of MS. Methods …
acid (TUDCA) supplementation ameliorated disease in mouse models of MS. Methods …
[PDF][PDF] Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A
…, T Bedke, E Javidi, B Rissiek, L Jank… - 2021 - jneuroinflammation.biomedcentral …
Background: Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T
cells are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With …
cells are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With …